Crude Pollen Allergen Extract

| Written by Kevin Facun

DESCRIPTION

The intellectual property (IP) is a Crude Pollen Extract used for diagnostics (skin allergy testing), and therapeutic (specific allergen immunotherapy) use. It includes 3 weeds, 15 grass, and 5 tree local pollen extracts currently solely manufactured by the Section of Allergy and Immunology (SAF) of Philippine General Hospital (PGH). These allergen extracts are all local plant flora

 

VALUE PROPOSITION

  • Wide array of pollen extracts: 3 weeds, 15 grass, and 5 tree
  • Tested and proven by clinical practitioners
  • All local pollen – applicable to Filipino patients
  • Widely available raw materials in the Philippines

 

MARKET APPLICATIONS AND COMMERCIAL OPPORTUNITIES

Globally, 22.1% of prevalence among 13-14 years old are reported. In the Philippines, 20% of the population has allergy symptoms of which 21% are children, 26% are teenagers, and 36.47% are adults. According to the National Nutrition and Health Survey, 2 out of every 10 Filipinos suffer from allergic rhinitis. During the period of 1986-2006, the cases of respiratory allergies doubled. This made the country one of the top Asian countries with the prevalence of common allergies. Filipino children aged 13-14 years old in effect revealed to have the highest incidence rates of allergic diseases.

Currently, the IP is being manufactured on a laboratory scale at PGH. It has proven sales at a pre-commercialization stage.

 

DEVELOPMENT STATUS

Ready and tested for manufacturing and distribution.

 

IP STATUS

Utility Model Granted

 

TYPE OF PARTNERSHIP BEING SOUGHT

  • Licensing. We are looking for IP licensees interested in expanding their line of products.
  • Co-Investment/Co-Funding. We are looking for partners and co-investors to fund further studies for characterized pollen extracts.

 

EVALUATION TESTS

The IP demonstrated the ability for allergen incorporation and release, with good physical properties that are useful in skin allergy testing.